Alime Ozlem Kirdar
Advertisement
Articles by Alime Ozlem Kirdar
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Rejects Summit’s PD-1×VEGF Bispecific Ivonescimab in EGFR-Mutated NSCLC, Citing Lack of Survival Benefit
2
Deals Roundup: J&J Buys Ollin, Lilly Adds Calytrix, and Novartis and Sanofi Strike Platform Pacts
3
FDA Approves AstraZeneca's Gefurulimab (Klygefa) for Generalized MG
4
FDA Approves Cosentyx as First Anti-IL-17 Biologic for Polymyalgia Rheumatica
5

